Cardiovascular risk management series: 2 - Using guidelines as a framework for cardiovascular risk management

2008 ◽  
Vol 1 (2) ◽  
pp. 77
Author(s):  
Susan Wells ◽  
Elinor Washbrook ◽  
Leif Erhardt
2017 ◽  
Vol 36 (6) ◽  
pp. 1387-1393 ◽  
Author(s):  
Dionicio A. Galarza-Delgado ◽  
Jose R. Azpiri-Lopez ◽  
Iris J. Colunga-Pedraza ◽  
Jesus A. Cardenas-de la Garza ◽  
Raymundo Vera-Pineda ◽  
...  

2017 ◽  
Vol 23 (10) ◽  
pp. 1471-1476 ◽  
Author(s):  
Valeria Raparelli ◽  
Susanna Morano ◽  
Flavia Franconi ◽  
Andrea Lenzi ◽  
Stefania Basili

2021 ◽  
Vol 26 (3S) ◽  
pp. 4558 ◽  
Author(s):  
S. V. Villevalde ◽  
A. E. Soloveva ◽  
N. E. Zvartau ◽  
N. G. Avdonina ◽  
A. N. Yakovlev ◽  
...  

The extent of the problem of heart failure determines the priority of the intention of developing and implementing an optimal model of medical care for this group of patients. The article describes the key components of the heart failure medical care (continuity, patient routing, educational activities) and provides examples of documents, protocols, checklists that can be used in real clinical practice by specialists in medical organizations in the regions of the Russian Federation.


2011 ◽  
Vol 61 (584) ◽  
pp. e105-e111 ◽  
Author(s):  
Anne-Cécile Schieber ◽  
Michelle Kelly-Irving ◽  
Christine Rolland ◽  
Anissa Afrite ◽  
Chantal Cases ◽  
...  

Hypertension ◽  
2020 ◽  
Vol 75 (6) ◽  
pp. 1593-1599 ◽  
Author(s):  
Dean S. Picone ◽  
Rewati A. Deshpande ◽  
Martin G. Schultz ◽  
Ricardo Fonseca ◽  
Norm R.C. Campbell ◽  
...  

Self-home blood pressure (BP) monitoring is recommended to guide clinical decisions on hypertension and is used worldwide for cardiovascular risk management. People usually make their own decisions when purchasing BP devices, which can be made online. If patients purchase nonvalidated devices (those not proven accurate according to internationally accepted standards), hypertension management may be based on inaccurate readings resulting in under- or over-diagnosis or treatment. This study aimed to evaluate the number, type, percentage validated, and cost of home BP devices available online. A search of online businesses selling devices for home BP monitoring was conducted. Multinational companies make worldwide deliveries, so searches were restricted to BP devices available for one nation (Australia) as an example of device availability through the global online marketplace. Validation status of BP devices was determined according to established protocols. Fifty nine online businesses, selling 972 unique BP devices were identified. These included 278 upper-arm cuff devices (18.3% validated), 162 wrist-cuff devices (8.0% validated), and 532 wrist-band wearables (0% validated). Most BP devices (92.4%) were stocked by international e-commerce businesses (eg, eBay, Amazon), but only 5.5% were validated. Validated cuff BP devices were more expensive than nonvalidated devices: median (interquartile range) of 101.1 (75.0–151.5) versus 67.4 (30.4–112.8) Australian Dollars. Nonvalidated BP devices dominate the online marketplace and are sold at lower cost than validated ones, which is a major barrier to accurate home BP monitoring and cardiovascular risk management. Before purchasing a BP device, people should check it has been validated at https://www.stridebp.org .


Diabetes Care ◽  
2020 ◽  
Vol 43 (7) ◽  
pp. 1427-1432 ◽  
Author(s):  
Antonio Ceriello ◽  
Eberhard Standl ◽  
Doina Catrinoiu ◽  
Baruch Itzhak ◽  
Nebojsa M. Lalic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document